Drugs / RegenerEyes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05169931 | Jan → Apr 2022 | dry eye syndrome | University of California, Los Angeles | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RegenerEyes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05169931 ↗ |
| Modality | Protein / enzyme biologic | “Biologic eye drop” NCT05169931 ↗ |
| Route | Topical | “Biologic eye drop” NCT05169931 ↗ |